Logo image of NAOV

NANOVIBRONIX INC (NAOV) Stock Fundamental Analysis

NASDAQ:NAOV - Nasdaq - US63008J7028 - Common Stock - Currency: USD

0.9545  +0.05 (+6.04%)

After market: 0.939 -0.02 (-1.62%)

Fundamental Rating

1

Taking everything into account, NAOV scores 1 out of 10 in our fundamental rating. NAOV was compared to 187 industry peers in the Health Care Equipment & Supplies industry. NAOV may be in some trouble as it scores bad on both profitability and health. NAOV has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NAOV had negative earnings in the past year.
NAOV had a negative operating cash flow in the past year.
NAOV had negative earnings in each of the past 5 years.
NAOV had a negative operating cash flow in each of the past 5 years.
NAOV Yearly Net Income VS EBIT VS OCF VS FCFNAOV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M

1.2 Ratios

NAOV has a Return On Assets (-12.72%) which is comparable to the rest of the industry.
With a decent Return On Equity value of -15.73%, NAOV is doing good in the industry, outperforming 64.71% of the companies in the same industry.
Industry RankSector Rank
ROA -12.72%
ROE -15.73%
ROIC N/A
ROA(3y)-83.46%
ROA(5y)-93.73%
ROE(3y)-284.23%
ROE(5y)-252.03%
ROIC(3y)N/A
ROIC(5y)N/A
NAOV Yearly ROA, ROE, ROICNAOV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K

1.3 Margins

With a Gross Margin value of 45.57%, NAOV is not doing good in the industry: 60.96% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of NAOV has grown nicely.
NAOV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.18%
GM growth 5Y2.22%
NAOV Yearly Profit, Operating, Gross MarginsNAOV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

More info and screens

1

2. Health

2.1 Basic Checks

NAOV does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NAOV has more shares outstanding
Compared to 5 years ago, NAOV has more shares outstanding
There is no outstanding debt for NAOV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NAOV Yearly Shares OutstandingNAOV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100K 200K 300K
NAOV Yearly Total Debt VS Total AssetsNAOV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

Based on the Altman-Z score of -2.55, we must say that NAOV is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of NAOV (-2.55) is worse than 65.78% of its industry peers.
NAOV has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of NAOV (0.07) is better than 62.03% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z -2.55
ROIC/WACCN/A
WACC9.03%
NAOV Yearly LT Debt VS Equity VS FCFNAOV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M -6M

2.3 Liquidity

NAOV has a Current Ratio of 0.47. This is a bad value and indicates that NAOV is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.47, NAOV is doing worse than 94.12% of the companies in the same industry.
A Quick Ratio of 0.22 indicates that NAOV may have some problems paying its short term obligations.
NAOV has a Quick ratio of 0.22. This is amonst the worse of the industry: NAOV underperforms 95.72% of its industry peers.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.22
NAOV Yearly Current Assets VS Current LiabilitesNAOV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

3

3. Growth

3.1 Past

NAOV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.35%, which is quite impressive.
NAOV shows a decrease in Revenue. In the last year, the revenue decreased by -6.53%.
Measured over the past years, NAOV shows a very strong growth in Revenue. The Revenue has been growing by 37.00% on average per year.
EPS 1Y (TTM)21.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55.05%
Revenue 1Y (TTM)-6.53%
Revenue growth 3Y14.59%
Revenue growth 5Y37%
Sales Q2Q%11.29%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NAOV Yearly Revenue VS EstimatesNAOV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
NAOV Yearly EPS VS EstimatesNAOV Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2018 -20 -40 -60 -80 -100

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NAOV. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NAOV Price Earnings VS Forward Price EarningsNAOV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NAOV Per share dataNAOV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

NAOV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NANOVIBRONIX INC

NASDAQ:NAOV (6/18/2025, 8:11:07 PM)

After market: 0.939 -0.02 (-1.62%)

0.9545

+0.05 (+6.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-13 2025-05-13
Earnings (Next)08-12 2025-08-12
Inst Owners2.31%
Inst Owner Change-94.55%
Ins Owners0.29%
Ins Owner Change0%
Market Cap2.46M
Analysts82.86
Price TargetN/A
Short Float %28.4%
Short Ratio0.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.93
P/FCF N/A
P/OCF N/A
P/B 0.07
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-14.83
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.27
FCFYN/A
OCF(TTM)-1.27
OCFYN/A
SpS1.03
BVpS13.83
TBVpS-1.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.72%
ROE -15.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.57%
FCFM N/A
ROA(3y)-83.46%
ROA(5y)-93.73%
ROE(3y)-284.23%
ROE(5y)-252.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.18%
GM growth 5Y2.22%
F-Score3
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 36.84%
Cap/Sales 0.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.47
Quick Ratio 0.22
Altman-Z -2.55
F-Score3
WACC9.03%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.05%
Cap/Sales(5y)0.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55.05%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.53%
Revenue growth 3Y14.59%
Revenue growth 5Y37%
Sales Q2Q%11.29%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-64.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.54%
OCF growth 3YN/A
OCF growth 5YN/A